Investigations  	Investigations  	 NNS	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
antifatigue  	antifatigue  	 NN	B-NP
and  	and  	 CC	O
antihypoxic  	antihypoxic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
Paecilomyces  	Paecilomyces  	 NNP	I-NP
hepiali  	hepiali  	 FW	I-NP
extract  	extract  	 FW	I-NP
Paecilomyces  	Paecilomyces  	 FW	I-NP
hepiali 	hepiali 	 FW	O
,  	,  	 ,	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
valuable  	valuable  	 JJ	O
and  	and  	 CC	O
effective  	effective  	 JJ	O
Chinese  	Chinese  	 JJ	O
medicinal  	medicinal  	 JJ	B-NP
herbs 	herbs 	 NN	I-NP
,  	,  	 ,	O
possesses  	possesses  	 VBZ	O
potential  	potential  	 JJ	B-NP
antioxidant 	antioxidant 	 NN	I-NP
,  	,  	 ,	O
immunomodulatory 	immunomodulatory 	 NN	B-NP
,  	,  	 ,	O
antitumor  	antitumor  	 NN	B-NP
and  	and  	 CC	O
anti‑inflammatory  	anti‑inflammatory  	 CD	B-NP
properties 	properties 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
aimed  	aimed  	 VBN	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
antifatigue  	antifatigue  	 NN	B-NP
and  	and  	 CC	O
antihypoxic  	antihypoxic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
Paecilomyces  	Paecilomyces  	 NNP	I-NP
hepiali  	hepiali  	 FW	I-NP
extract  	extract  	 FW	I-NP
( 	( 	 -LRB-	O
PHC 	PHC 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
mouse  	mouse  	 NN	O
model 	model 	 NN	O
.  	.  	 .	O
Using  	Using  	 VBG	O
a  	a  	 DT	O
rotating  	rotating  	 JJ	O
rod 	rod 	 NN	O
,  	,  	 ,	O
forced  	forced  	 VBN	O
swimming  	swimming  	 NN	O
and  	and  	 CC	O
running  	running  	 VBG	B-NP
assessment 	assessment 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
antifatigue  	antifatigue  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PHC  	PHC  	 NNP	I-NP
was  	was  	 VBD	O
determined 	determined 	 VBN	O
.  	.  	 .	O
PHC  	PHC  	 NNP	B-NP
administration  	administration  	 NN	I-NP
for  	for  	 IN	O
7 days  	7 days  	 NNP	O
had  	had  	 VBD	O
no  	no  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
mouse  	mouse  	 NN	O
horizontal  	horizontal  	 NNS	O
or  	or  	 CC	O
vertical  	vertical  	 JJ	B-NP
movement 	movement 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
no  	no  	 DT	O
neurotoxicity  	neurotoxicity  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
selected  	selected  	 JJ	O
doses  	doses  	 NNS	O
was  	was  	 VBD	O
observed 	observed 	 VBN	O
.  	.  	 .	O
Using  	Using  	 VBG	O
a  	a  	 DT	O
normobaric  	normobaric  	 JJ	B-NP
hypoxia 	hypoxia 	 NN	I-NP
,  	,  	 ,	O
sodium  	sodium  	 FW	B-NP
nitrite  	nitrite  	 FW	I-NP
toxicosis  	toxicosis  	 FW	I-NP
and  	and  	 CC	O
acute  	acute  	 JJ	O
cerebral  	cerebral  	 JJ	B-NP
ischemia  	ischemia  	 JJ	I-NP
assessments 	assessments 	 NNS	I-NP
,  	,  	 ,	O
PHC  	PHC  	 NNP	B-NP
was  	was  	 VBD	O
confirmed  	confirmed  	 VBN	O
to  	to  	 TO	O
possess  	possess  	 VB	O
antihypoxic  	antihypoxic  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
PHC  	PHC  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	O
7 days  	7 days  	 NNP	O
significantly  	significantly  	 RB	O
enhanced  	enhanced  	 VBN	O
the  	the  	 DT	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
liver  	liver  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
adenosine  	adenosine  	 JJ	B-NP
triphosphate 	triphosphate 	 NN	I-NP
,  	,  	 ,	O
superoxide  	superoxide  	 JJ	B-NP
dismutase  	dismutase  	 NN	I-NP
and  	and  	 CC	O
glutathione  	glutathione  	 JJ	B-NP
peroxidase 	peroxidase 	 NN	I-NP
,  	,  	 ,	O
prior  	prior  	 RB	O
to  	to  	 TO	O
and  	and  	 CC	O
following  	following  	 VBG	O
60 min  	60 min  	 NN	O
of  	of  	 IN	O
swimming 	swimming 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
antioxidant‑associated  	antioxidant‑associated  	 CD	B-NP
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
livers  	livers  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mice  	mice  	 NNS	O
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
using  	using  	 VBG	O
western  	western  	 JJ	O
blotting 	blotting 	 NN	O
.  	.  	 .	O
PHC  	PHC  	 NNP	B-NP
effectively  	effectively  	 RB	O
increased  	increased  	 VBD	O
the  	the  	 DT	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	O
phosphorylated  	phosphorylated  	 NNS	O
( 	( 	 -LRB-	O
p 	p 	 LS	O
) 	) 	 -RRB-	O
‑5 	‑5 	 NNP	O
' 	' 	 POS	O
‑monophosphate  	‑monophosphate  	 NNP	O
( 	( 	 -LRB-	O
AMP 	AMP 	 NNP	B-NP
) 	) 	 -RRB-	O
‑activated  	‑activated  	 FW	O
protein  	protein  	 FW	O
kinase  	kinase  	 FW	O
( 	( 	 -LRB-	O
AMPK 	AMPK 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
p‑protein  	p‑protein  	 NNP	O
kinase B  	kinase B  	 NNP	O
( 	( 	 -LRB-	O
AKT 	AKT 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
p‑mammalian  	p‑mammalian  	 CD	O
target  	target  	 NN	O
of  	of  	 IN	O
rapamycin  	rapamycin  	 NNS	B-NP
( 	( 	 -LRB-	O
mTOR 	mTOR 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
PHC  	PHC  	 NNP	B-NP
efficiently  	efficiently  	 RB	O
enhanced  	enhanced  	 JJ	O
endurance  	endurance  	 NN	O
from  	from  	 IN	O
fatigue  	fatigue  	 NN	O
and  	and  	 CC	O
had  	had  	 VBD	O
antihypoxic  	antihypoxic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
through  	through  	 IN	O
elevation  	elevation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
antioxidant  	antioxidant  	 JJ	B-NP
capacity  	capacity  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
liver 	liver 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
in  	in  	 IN	O
part  	part  	 NN	O
through  	through  	 IN	O
the  	the  	 DT	O
AMPK  	AMPK  	 NNP	B-NP
and  	and  	 CC	O
AKT 	AKT 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
mTOR  	mTOR  	 JJ	I-NP
pathways 	pathways 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
indicate  	indicate  	 VBP	O
the  	the  	 DT	O
potential  	potential  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
natural  	natural  	 JJ	O
product  	product  	 NN	O
as  	as  	 IN	O
an  	an  	 DT	O
antioxidant  	antioxidant  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
fatigue 	fatigue 	 NN	O
,  	,  	 ,	O
hypoxia  	hypoxia  	 NN	B-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
associated  	associated  	 JJ	O
diseases 	diseases 	 NNS	O
.  	.  	 .	O
